Literature DB >> 27461384

SPECT-CT/VQ versus CTPA for diagnosing pulmonary embolus and other lung pathology: Pre-existing lung disease should not be a contraindication.

Kartik Dev Bhatia1, Chaitanya Ambati1, Rajiv Dhaliwal1, Royce Paschkewitz1,2, Eugene Hsu1, Bao Ho1, Andy Young1, Louise Emmett1.   

Abstract

INTRODUCTION: Single Photon Emission Computed Tomography-Ventilation-Perfusion (SPECT-VQ) with low-dose CT (SPECT-CT/VQ) has equivalent diagnostic accuracy to CTPA for diagnosing pulmonary embolus (PE) while using lower radiation doses, but is underutilized owing to perceived inaccuracy of scintigraphy in the setting of pre-existing lung disease. This study assesses the accuracy of SPECT-CT/VQ compared with CTPA for the diagnosis of PE, including in patients with pre-existing lung disease.
METHODS: Retrospective non-inferiority cohort study of all patients who underwent SPECT-CT/VQ scanning at St Vincent's Hospital, NSW, from June 2012 to November 2013, who also had a CTPA within the same admission and <72 h apart (n = 102).
RESULTS: SPECT-CT/VQ had 100% sensitivity and 94.4% specificity when compared with CTPA. Of the 102 patients, 14 were lung transplant patients, and 27 had other pre-existing lung disease (41/102, 40.2%), with SPECT-CT/VQ having a sensitivity of 100% and specificity of 97.2% in this patient group. Non-inferiority of SPECT-CT/VQ was demonstrated at a significance level of 0.005.
CONCLUSION: SPECT-CT/VQ has high sensitivity and specificity for diagnosing PE compared with CTPA, even among patients with pre-existing lung disease, with lower radiation doses.
© 2016 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  CTPA; SPECT; VQ; pulmonary embolus; radiation dose

Mesh:

Year:  2016        PMID: 27461384     DOI: 10.1111/1754-9485.12471

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  4 in total

Review 1.  Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients.

Authors:  Vincent Cascio; Man Hon; Linda B Haramati; Animesh Gour; Peter Spiegler; Sanjeev Bhalla; Douglas S Katz
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

Review 2.  Molecular imaging as a tool for evaluation of COVID-19 sequelae - A review of literature.

Authors:  Kunal R Chandekar; Swayamjeet Satapathy; Harmandeep Singh; Anish Bhattacharya
Journal:  World J Radiol       Date:  2022-07-28

Review 3.  Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE.

Authors:  Jeeban P Das; Randy Yeh; Heiko Schöder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-22       Impact factor: 9.236

4.  Single photon emission computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?

Authors:  Stefan Vöö; Sabina Dizdarevic
Journal:  Nucl Med Commun       Date:  2020-09       Impact factor: 1.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.